“…Unlike the previously mentioned methods, the MS-based methodology has been widely used in the genetic characterization of human samples, involving a total of 428 samples in 20 different studies. Despite the participation of a greater number of European countries, France clustered 77.3% of the human samples analyzed ( Ajzenberg et al., 2009 ; Ajzenberg et al., 2015 ), followed by Portugal (11.7%) ( Ajzenberg et al., 2009 ; Vilares et al., 2017 ), Denmark (4.7%) ( Jokelainen et al., 2018 ), and Belgium (4.4%) ( Gisbert Algaba et al., 2020 ); most of the other countries contributed with up to three single isolates (Austria, Germany, Romania, Serbia, The Netherlands, and UK). Concerning strain types detected in human population, 86.4% corresponded with type II strains, the types I and III were found in low proportions (2.6 and 3% respectively), and those of MRA infections corresponded to 6.3% of cases.…”